bioAffinity Technologies Files S-1 Amendment with Updated Exhibits
bioAffinity Technologies, Inc. has filed an amendment to its S-1 registration statement, primarily updating and incorporating various exhibits. These exhibits include forms of placement agency agreements, warrants, certificates of incorporation and bylaws, as well as numerous material agreements related to employment, consulting, and past financing activities. The amendment does not appear to introduce new financial results or significant business developments beyond the incorporation of these documents.
Key Highlights
- bioAffinity Technologies, Inc. filed an amendment to its S-1 registration statement.
- The amendment includes updated exhibits such as the Form of Placement Agency Agreement and various Certificates of Incorporation and Bylaws.
- Several forms of warrants and agreements related to past financings and operations are referenced.
- The filing also incorporates by reference numerous employment agreements, consulting agreements, and other material contracts.
Price Impact
More from BIAF
bioAffinity Technologies Calls Special Meeting for Warrant, Share Authorization Votes
bioAffinity Technologies Reports Q2 Net Loss of $3.37M; Going Concern Doubt
bioAffinity Q2 Revenue $1.5M, Net Loss $3.4M; CyPath Lung Volume +216%